» Articles » PMID: 22145815

STAT3 Signaling After Traumatic Brain Injury

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2011 Dec 8
PMID 22145815
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes respond to trauma by stimulating inflammatory signaling. In studies of cerebral ischemia and spinal cord injury, astrocytic signaling is mediated by the cytokine receptor glycoprotein 130 (gp130) and Janus kinase (Jak) which phosphorylates the transcription factor signal transducer and activator of transcription-3 (STAT3). To determine if STAT3 is activated after traumatic brain injury (TBI), adult male Sprague-Dawley rats received moderate parasagittal fluid-percussion brain injury or sham surgery, and then the ipsilateral cortex and hippocampus were analyzed at various post-traumatic time periods for up to 7 days. Western blot analyses indicated that STAT3 phosphorylation significantly increased at 30 min and lasted for 24 h post-TBI. A significant increase in gp130 and Jak2 phosphorylation was also observed. Confocal microscopy revealed that STAT3 was localized primarily within astrocytic nuclei. At 6 and 24 h post-TBI, there was also an increased expression of STAT3 pathway-related genes: suppressor of cytokine signaling 3, nitric oxide synthase 2, colony stimulating factor 2 receptor β, oncostatin M, matrix metalloproteinase 3, cyclin-dependent kinase inhibitor 1A, CCAAT/enhancer-binding protein β, interleukin-2 receptor γ, interleukin-4 receptor α, and α-2-macroglobulin. These results clarify some of the signaling pathways operative in astrocytes after TBI and demonstrate that the gp130-Jak2-STAT3 signaling pathway is activated after TBI in astrocytes.

Citing Articles

The role of microglia in Neuroinflammation associated with cardiopulmonary bypass.

Meng L, Gu T, Yu P, Zhang Z, Wei Z Front Cell Neurosci. 2025; 18:1496520.

PMID: 39742156 PMC: 11685197. DOI: 10.3389/fncel.2024.1496520.


Mitochondrial complex III-derived ROS amplify immunometabolic changes in astrocytes and promote dementia pathology.

Barnett D, Zimmer T, Booraem C, Palaguachi F, Meadows S, Xiao H bioRxiv. 2024; .

PMID: 39229090 PMC: 11370371. DOI: 10.1101/2024.08.19.608708.


Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling.

Frago L, Burgos-Ramos E, Rodriguez-Perez M, Canelles S, Arilla-Ferreiro E, Argente J Int J Mol Sci. 2024; 25(11).

PMID: 38891902 PMC: 11172028. DOI: 10.3390/ijms25115716.


Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.

Li J, Haj Ebrahimi A, Ali A Int J Mol Sci. 2024; 25(10).

PMID: 38791206 PMC: 11121252. DOI: 10.3390/ijms25105169.


NF-κB and JAK/STAT Signaling Pathways as Crucial Regulators of Neuroinflammation and Astrocyte Modulation in Spinal Cord Injury.

Ageeva T, Rizvanov A, Mukhamedshina Y Cells. 2024; 13(7.

PMID: 38607020 PMC: 11011519. DOI: 10.3390/cells13070581.